Skip to main content
logo
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.140
+0.030 (2.70%)
At close: Aug 14, 2026, 4:00 PM EDT
1.130
-0.010 (-0.88%)
After-hours: Aug 14, 2026, 4:10 PM EDT

Marker Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.553.556.593.313.511.24
Revenue Growth
-33.67%-46.19%99.06%-5.76%182.96%166.01%
Gross Profit
-7.96-8.25-6.88-7.11-8.45-26.55
Operating Income
-12.01-12.44-11.12-14.58-19.79-39.48
Net Income
-10.9-12.16-10.73-8.24-29.93-41.88
Earnings Per Share
-0.63-0.79-1.19-0.94-3.59-5.47
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.9216.0719.1915.1111.7842.35
Total Debt
-----11.87
Net Cash (Debt)
14.9216.0719.1915.1111.7830.48
Net Cash Growth
8.93%-16.28%27.01%28.26%-61.35%235.15%
Net Cash Per Share
0.861.052.141.721.413.98

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.92-12.01-10.91-16.44-26.97-27.28
Capital Expenditures
------3.13
Free Cash Flow
-7.92-12.01-10.91-16.44-26.97-30.41
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-224.43%-232.68%-104.33%-214.60%-240.64%-
Operating Margin
-338.49%-350.67%-168.69%-440.37%-563.28%-3179.32%
Pretax Margin
-307.67%-343.39%-162.06%-424.09%-562.85%-3372.68%
Profit Margin
-307.24%-342.96%-162.82%-248.76%-851.87%-3372.68%
FCF Margin
-223.27%-338.74%-165.53%-496.51%-767.66%-2449.11%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.417.015.0514.776.4663.58